Trupti Trivedi

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

Harvey D. White, Claes Held, Ralph Stewart et al. · American Heart Journal · 2010 · 126 citations

Medicine, Cardiology, Pharmacology +17

Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration

Karl G. Csaky, Pravin U. Dugel, Amy Pierce et al. · Ophthalmology · 2014 · 74 citations

Medicine, Ophthalmology, Pharmacology +14

CLINICAL EVALUATION OF PAZOPANIB EYE DROPS IN HEALTHY SUBJECTS AND IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Rishi P. Singh, John I. Wurzelmann, Ye Li et al. · Retina · 2014 · 29 citations

Medicine, Ophthalmology, Pharmacology +17

Peripheral artery disease, biomarkers, and darapladib

Jeffrey S. Berger, Christie M. Ballantyne, Michael H. Davidson et al. · American Heart Journal · 2011 · 24 citations · Full text

Medicine, Cardiology, Clinical Sciences +12

Predictive Models of Choroidal Neovascularization and Geographic Atrophy Incidence Applied to Clinical Trial Design

Linda McCarthy, Paul J. Newcombe, John C. Whittaker et al. · American Journal of Ophthalmology · 2012 · 13 citations

Medicine, Ophthalmology, Ocular Pathology +6